GA · State regulatory reference
Georgia.
Moderate
Telemedicine runs under Ga. Comp. R. & Regs. 360-3-.07, which lets a physician-patient relationship form remotely when the provider uses technology 'equal or superior' to an in-person exam and holds telemedicine to the same standard of care. Compounding under Chapter 480-11 expressly adopts USP <795> and <797> plus state facility, quality-assurance, and recordkeeping rules. No Georgia-board enforcement specific to peptides or GLP-1 compounding was found; the Board's December 2023 rollback of COVID-era controlled-substance tele-prescribing flexibility is now complete and applies mainly to controlled substances.
Last reviewed · 2026-05-25 · verified entry
Agencies
TPC notes
Telehealth
Under 360-3-.07, an initial visit for non-controlled drugs may be established via synchronous audio-video where the exam is 'equal or superior' to in-person, with an annual in-person effort; controlled substances face tighter limits.
Compounding
Board of Pharmacy rule 480-11-.02 mandates USP <795> (non-sterile) and <797> (sterile), layered with state facility, drug-control, recordkeeping, and semiannual clean-room certification requirements; patient-specific 503A compounding needs only a Georgia pharmacy license.
Sources